메뉴 건너뛰기




Volumn 140, Issue 5-6, 2010, Pages 73-77

Use of the CHADS2 risk score to guide antithrombotic treatment in patients with atrial fibrillation - Room for improvement

Author keywords

Anticoagulation treatment; Antithrombotic therapy; Atrial fibrillation; Stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; FIBRINOLYTIC AGENT;

EID: 76649113385     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (7)

References (28)
  • 1
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
    • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983-8.
    • (1991) Stroke , vol.22 , Issue.8 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 2
    • 34547693119 scopus 로고    scopus 로고
    • Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial
    • Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet. 2007;370(9586):493- 503.
    • (2007) Lancet , vol.370 , Issue.9586 , pp. 493-503
    • Mant, J.1    Hobbs, F.D.2    Fletcher, K.3    Roalfe, A.4    Fitzmaurice, D.5    Lip, G.Y.6
  • 3
    • 33744945247 scopus 로고    scopus 로고
    • Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial
    • Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367(9526):1903-12.
    • (2006) Lancet , vol.367 , Issue.9526 , pp. 1903-1912
    • Connolly, S.1    Pogue, J.2    Hart, R.3    Pfeffer, M.4    Hohnloser, S.5    Chrolavicius, S.6
  • 4
    • 34347394385 scopus 로고    scopus 로고
    • Meta-Analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart RG, Pearse LA, Aguillar MT. Meta-Analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-67.
    • (2007) Ann Intern Med , vol.146 , pp. 857-867
    • Hart, R.G.1    Pearse, L.A.2    Aguillar, M.T.3
  • 5
    • 33846303925 scopus 로고    scopus 로고
    • Atrial fibrillation: Estimated excess rate of stroke due to lacking adherence to guidelines
    • Zehnder BS, Schaer BA, Jeker U, Cron TA, Osswald S. Atrial fibrillation: estimated excess rate of stroke due to lacking adherence to guidelines. Swiss Med Wkly. 2006;136(47-48):757-60.
    • (2006) Swiss Med Wkly , vol.136 , Issue.47-48 , pp. 757-760
    • Zehnder, B.S.1    Schaer, B.A.2    Jeker, U.3    Cron, T.A.4    Osswald, S.5
  • 6
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation
    • Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864-70.
    • (2001) JAMA , vol.285 , Issue.22 , pp. 2864-2870
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3    Boechler, M.4    Rich, M.W.5    Radford, M.J.6
  • 7
    • 0035155445 scopus 로고    scopus 로고
    • Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J. 2001;22(20):1852-923.
    • Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J. 2001;22(20):1852-923.
  • 8
    • 33845718250 scopus 로고    scopus 로고
    • Antithrombotic treatment in real-life atrial fibrillation patients: A report from the Euro Heart Survey on Atrial Fibrillation
    • Nieuwlaat R, Capucci A, Lip GY, Olsson SB, Prins MH, Nieman FH, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2006;27(24):3018-26.
    • (2006) Eur Heart J , vol.27 , Issue.24 , pp. 3018-3026
    • Nieuwlaat, R.1    Capucci, A.2    Lip, G.Y.3    Olsson, S.B.4    Prins, M.H.5    Nieman, F.H.6
  • 9
    • 0344861847 scopus 로고    scopus 로고
    • Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice?
    • Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA. 2003;290(20):2685-92.
    • (2003) JAMA , vol.290 , Issue.20 , pp. 2685-2692
    • Go, A.S.1    Hylek, E.M.2    Chang, Y.3    Phillips, K.A.4    Henault, L.E.5    Capra, A.M.6
  • 10
    • 0028067590 scopus 로고
    • A multifactorial intervention to reduce the risk of falling among elderly people living in the community
    • Tinetti ME, Baker DI, McAvay G, Claus EB, Garrett P, Gottschalk M, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med. 1994;331(13):821-7.
    • (1994) N Engl J Med , vol.331 , Issue.13 , pp. 821-827
    • Tinetti, M.E.1    Baker, D.I.2    McAvay, G.3    Claus, E.B.4    Garrett, P.5    Gottschalk, M.6
  • 12
    • 42049099458 scopus 로고    scopus 로고
    • Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls
    • Garwood CL, Corbett TL. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls. Ann Pharmacother. 2008;42(4):523-32.
    • (2008) Ann Pharmacother , vol.42 , Issue.4 , pp. 523-532
    • Garwood, C.L.1    Corbett, T.L.2
  • 13
    • 19544361856 scopus 로고    scopus 로고
    • Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall
    • Gage BF, Birman-Deych E, Kerzner R, Radford MJ, Nilasena DS, Rich MW. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med. 2005;118(6):612-7.
    • (2005) Am J Med , vol.118 , Issue.6 , pp. 612-617
    • Gage, B.F.1    Birman-Deych, E.2    Kerzner, R.3    Radford, M.J.4    Nilasena, D.S.5    Rich, M.W.6
  • 14
    • 27744591199 scopus 로고    scopus 로고
    • The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapy
    • Bond AJ, Molnar FJ, Li M, Mackey M, Man-Son-Hing M. The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapy. Thromb J. 2005;3(1):1.
    • (2005) Thromb J , vol.3 , Issue.1 , pp. 1
    • Bond, A.J.1    Molnar, F.J.2    Li, M.3    Mackey, M.4    Man-Son-Hing, M.5
  • 15
    • 0025954635 scopus 로고
    • Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation
    • Kutner M, Nixon G, Silverstone F. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med. 1991;151(10):1950-3.
    • (1991) Arch Intern Med , vol.151 , Issue.10 , pp. 1950-1953
    • Kutner, M.1    Nixon, G.2    Silverstone, F.3
  • 17
    • 0025233476 scopus 로고
    • Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project
    • Chang HJ, Bell JR, Deroo DB, Kirk JW, Wasson JH. Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project. Arch Intern Med. 1990;150(1):83-6.
    • (1990) Arch Intern Med , vol.150 , Issue.1 , pp. 83-86
    • Chang, H.J.1    Bell, J.R.2    Deroo, D.B.3    Kirk, J.W.4    Wasson, J.H.5
  • 18
    • 0034827738 scopus 로고    scopus 로고
    • Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation
    • Bungard TJ, Ghali WA, McAlister FA, Buchan AM, Cave AJ, Hamilton PG, et al. Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation. CMAJ. 2001;165(3):301-2.
    • (2001) CMAJ , vol.165 , Issue.3 , pp. 301-302
    • Bungard, T.J.1    Ghali, W.A.2    McAlister, F.A.3    Buchan, A.M.4    Cave, A.J.5    Hamilton, P.G.6
  • 19
    • 0027457034 scopus 로고
    • Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group
    • Fihn SD, McDonell M, Martin D, Henikoff J, Vermes D, Kent D, et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med. 1993;118(7):511-20.
    • (1993) Ann Intern Med , vol.118 , Issue.7 , pp. 511-520
    • Fihn, S.D.1    McDonell, M.2    Martin, D.3    Henikoff, J.4    Vermes, D.5    Kent, D.6
  • 20
    • 0031801103 scopus 로고    scopus 로고
    • Risk of major hemorrhage for outpatients treated with warfarin
    • McMahan DA, Smith DM, Carey MA, Zhou XH. Risk of major hemorrhage for outpatients treated with warfarin. J Gen Intern Med. 1998;13(5):311-6.
    • (1998) J Gen Intern Med , vol.13 , Issue.5 , pp. 311-316
    • McMahan, D.A.1    Smith, D.M.2    Carey, M.A.3    Zhou, X.H.4
  • 21
    • 4744355196 scopus 로고    scopus 로고
    • Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients
    • Shireman TI, Howard PA, Kresowik TF, Ellerbeck EF. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke. 2004;35(10): 2362-7.
    • (2004) Stroke , vol.35 , Issue.10 , pp. 2362-2367
    • Shireman, T.I.1    Howard, P.A.2    Kresowik, T.F.3    Ellerbeck, E.F.4
  • 22
    • 34249715284 scopus 로고    scopus 로고
    • Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation
    • Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation. 2007;115(21):2689-96.
    • (2007) Circulation , vol.115 , Issue.21 , pp. 2689-2696
    • Hylek, E.M.1    Evans-Molina, C.2    Shea, C.3    Henault, L.E.4    Regan, S.5
  • 23
    • 33846484956 scopus 로고    scopus 로고
    • Impact of anticoagulation on rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage
    • Wolf AT, Wasan SK, Saltzman JR. Impact of anticoagulation on rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage. Am J Gastroenterol. 2007;102(2):290-6.
    • (2007) Am J Gastroenterol , vol.102 , Issue.2 , pp. 290-296
    • Wolf, A.T.1    Wasan, S.K.2    Saltzman, J.R.3
  • 24
    • 33644650849 scopus 로고    scopus 로고
    • Optimal INR for prevention of stroke and death in atrial fibrillation: A critical appraisal
    • Oden A, Fahlen M, Hart RG. Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. Thromb Res. 2006;117(5):493-9.
    • (2006) Thromb Res , vol.117 , Issue.5 , pp. 493-499
    • Oden, A.1    Fahlen, M.2    Hart, R.G.3
  • 25
    • 44249124516 scopus 로고    scopus 로고
    • Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice
    • Abdelhafiz AH, Wheeldon NM. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice. Am J Geriatr Pharmacother. 2008;6(1):1-11.
    • (2008) Am J Geriatr Pharmacother , vol.6 , Issue.1 , pp. 1-11
    • Abdelhafiz, A.H.1    Wheeldon, N.M.2
  • 26
    • 41849119802 scopus 로고    scopus 로고
    • Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
    • Nieuwlaat R, Dinh T, Olsson SB, Camm AJ, Capucci A, Tieleman RG, et al. Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J. 2008;29(7):915-22.
    • (2008) Eur Heart J , vol.29 , Issue.7 , pp. 915-922
    • Nieuwlaat, R.1    Dinh, T.2    Olsson, S.B.3    Camm, A.J.4    Capucci, A.5    Tieleman, R.G.6
  • 27
    • 57849167181 scopus 로고    scopus 로고
    • Characteristics of bleeding complications in patients with anticoagulant treatment
    • Rothschild S, Conen D. Characteristics of bleeding complications in patients with anticoagulant treatment. Swiss Med Wkly. 2008;138(47-48):719-24.
    • (2008) Swiss Med Wkly , vol.138 , Issue.47-48 , pp. 719-724
    • Rothschild, S.1    Conen, D.2
  • 28
    • 33344461585 scopus 로고    scopus 로고
    • Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
    • Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151(3):713-9.
    • (2006) Am Heart J , vol.151 , Issue.3 , pp. 713-719
    • Gage, B.F.1    Yan, Y.2    Milligan, P.E.3    Waterman, A.D.4    Culverhouse, R.5    Rich, M.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.